7:00 am Albany Molecular signed an agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals or $38.2 mln in cash; expected to add between $0.06 and $0.07 to adjusted EPS for 2014
View todays social media effects on AMRI
View the latest stocks trending across Twitter. Click to view dashboard